Clinical Risk Score and COVID-19

被引：0
作者：
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj [1 ,2 ]
机构：
[1] Dr DY Patil Univ, Pune, Maharashtra, India
[2] Joseph Ayobabalola Univ, Ikeji Arakeji, Nigeria
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2021年 / 36卷 / 07期
关键词：
D O I：
10.1007/s11606-021-06721-9
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：2151 / 2151
页数：1
相关论文
共 4 条
[1]   Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium [J].
Hicks, JM ;
Haeckel, R ;
Price, CP ;
Lewandrowski, K ;
Wu, AHB .
CLINICA CHIMICA ACTA, 2001, 303 (1-2) :1-17
[2]   Derivation of a Clinical Risk Score to Predict 14-Day Occurrence of Hypoxia, ICU Admission, and Death Among Patients with Coronavirus Disease 2019 [J].
Levine, David M. ;
Lipsitz, Stuart R. ;
Co, Zoe ;
Song, Wenyu ;
Dykes, Patricia C. ;
Samal, Lipika .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (03) :730-737
[3]   Influence of hemolysis on routine clinical chemistry testing [J].
Lippi, G ;
Salvagno, GL ;
Montagnana, M ;
Brocco, G ;
Guidi, GC .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (03) :311-316
[4]   COVID-19 related immune hemolysis and thrombocytopenia [J].
Sahu, Kamal Kant ;
Borogovac, Azra ;
Cerny, Jan .
JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) :1164-1170
1